2026 Q4 - tulosraportti
11 päivää sitten
‧1 t 16 min
0,56 DKK/osake
Irtoamispäivä 3.12.
0,45%Tuotto/v
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 54 | ||
| 438 | ||
| 338 | ||
| 14 | ||
| 571 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Tuotteita joiden kohde-etuutena tämä arvopaperi
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2027 Q1 - tulosraportti 28.1.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q4 - tulosraportti 5.11. | ||
2026 Q3 - tulosraportti 26.8. | ||
2026 Q2 - tulosraportti 6.5. | ||
2026 Q1 - tulosraportti 4.2. | ||
2025 Q4 - tulosraportti 5.11.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·2 t sitten · MuokattuThe buyback supports the share price for a longer time, I think. Probably not something shorters like ... During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027.
- 3 päivää sittenShort squeeze!?....... asked AI on a Monday morning .... so you can form your own opinion based on your own analysis. I own shares in Ambu: No, Ambu A/S is not in a proper short squeeze right now, but the stock is experiencing upward price pressure and continues to have a noticeable short interest. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) Here is the current status for the Ambu stock at Jyske Bank and the figures from the Danish Financial Supervisory Authority: [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) 1. Short interest is declining, but still noticeable • Current short interest: According to the latest figures from the Danish FSA's list of net short positions, 5.53 % of Ambu's share capital is shorted (as of November 13, 2026). This makes Ambu the fourth most shorted stock in Denmark. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) • Development in short positions: The share has decreased slightly from around 6.1 % at the end of October 2026 (and a peak of over 7 % earlier in the year). This indicates that some short sellers are already in the process of closing their positions at a controlled pace rather than in panic. [1] (https://www.zirium.dk/analyse/ambu/2026-06-01), [2] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267) 2. Price development shows strong progress – not a panic explosion • Recent price increases: Following the annual report on November 5, 2026 (where the company reported strong growth in Endoscopy Solutions and a share buyback of DKK 400 million), the stock has risen nicely. On Friday, November 13, the stock closed at DKK 91.65 after an increase of 5.04 % on the day and nearly 17 % over the past month. [1] (https://npinvestor.dk/aktier/ambu-a-s/), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) • Why it is not a short squeeze: A classic short squeeze is characterized by extreme, sudden price increases of 20–50 % or more in a few days driven by forced buybacks. Ambu's rise has been more gradual and supported by concrete financial figures and buyback programs. [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://npinvestor.dk/aktier/ambu-a-s/) Conclusion Although the increases following the financial report undoubtedly put pressure on the funds that have shorted the stock, the movement looks more like a regular bull run driven by good news combined with the ongoing unwinding of short positions. With over 5.5 % of the shares still shorted, however, there remains a moderate potential for further upward price pressure if the stock continues to rise. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://npinvestor.dk/aktier/ambu-a-s/), [3] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267), [4] (https://tradedesk.dk/stock/ambu-b.co) Would you like me to set up a task that notifies you if the short interest or the price in Ambu changes significantly, or do you want to see which specific hedge funds have shorted the stock right now? Good day out there.
- ·3 päivää sittenHard to see the rationale behind the increase Ambu has had the last 6 months. Anyone who can elaborate or are people just buying on a gut feeling?Q4 of the 2024/25 financial year and Q1 and Q2 of 2025/26 were barely as good, so in the spring the market was skeptical towards Ambu. The second half of the recently reported financial statement was better + they are getting some tariff refunds back from the USA, which fall straight into the cash register. They are facing a long series of product launches, and this is presumably interpreted as a catalyst for future growth. Operations yield 16% of revenue and there is no debt, so the market is also starting to sense share buybacks and/or dividends if the extensive product program does not swallow it all. Finally, the entire medtech sector has enjoyed a tailwind since the spring.
- ·3 päivää sittenIs there anyone who can provide a technical analysis of Ambu? Thanks in advance and have a good weekendinput from Investtech: Pt. at resistance/support at 91. Next resistance at 108 in the medium term and 115 in the long term. Buy signal from an inverse-head-and-shoulders pattern upon the breakout up through the resistance at 75.06 kroner. Further rise to 109 kroner or more is signaled. Not from Investtech: Last Friday the price closed for the first time since January above 90 - even above the resistance at 91 - and even at the day's highest price. All in all very positive signals.
- ·3 päivää sittenPrice target raised from 72 to 83 kr. https://www.nordnet.dk/markedet/nyheder/b080350a-c8ad-4425-b021-0171824649e7
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 359 766 | 359 766 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 359 766 | 359 766 | 0 | 0 |
2026 Q4 - tulosraportti
11 päivää sitten
‧1 t 16 min
0,56 DKK/osake
Irtoamispäivä 3.12.
0,45%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·2 t sitten · MuokattuThe buyback supports the share price for a longer time, I think. Probably not something shorters like ... During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027.
- 3 päivää sittenShort squeeze!?....... asked AI on a Monday morning .... so you can form your own opinion based on your own analysis. I own shares in Ambu: No, Ambu A/S is not in a proper short squeeze right now, but the stock is experiencing upward price pressure and continues to have a noticeable short interest. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) Here is the current status for the Ambu stock at Jyske Bank and the figures from the Danish Financial Supervisory Authority: [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) 1. Short interest is declining, but still noticeable • Current short interest: According to the latest figures from the Danish FSA's list of net short positions, 5.53 % of Ambu's share capital is shorted (as of November 13, 2026). This makes Ambu the fourth most shorted stock in Denmark. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) • Development in short positions: The share has decreased slightly from around 6.1 % at the end of October 2026 (and a peak of over 7 % earlier in the year). This indicates that some short sellers are already in the process of closing their positions at a controlled pace rather than in panic. [1] (https://www.zirium.dk/analyse/ambu/2026-06-01), [2] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267) 2. Price development shows strong progress – not a panic explosion • Recent price increases: Following the annual report on November 5, 2026 (where the company reported strong growth in Endoscopy Solutions and a share buyback of DKK 400 million), the stock has risen nicely. On Friday, November 13, the stock closed at DKK 91.65 after an increase of 5.04 % on the day and nearly 17 % over the past month. [1] (https://npinvestor.dk/aktier/ambu-a-s/), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) • Why it is not a short squeeze: A classic short squeeze is characterized by extreme, sudden price increases of 20–50 % or more in a few days driven by forced buybacks. Ambu's rise has been more gradual and supported by concrete financial figures and buyback programs. [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://npinvestor.dk/aktier/ambu-a-s/) Conclusion Although the increases following the financial report undoubtedly put pressure on the funds that have shorted the stock, the movement looks more like a regular bull run driven by good news combined with the ongoing unwinding of short positions. With over 5.5 % of the shares still shorted, however, there remains a moderate potential for further upward price pressure if the stock continues to rise. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://npinvestor.dk/aktier/ambu-a-s/), [3] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267), [4] (https://tradedesk.dk/stock/ambu-b.co) Would you like me to set up a task that notifies you if the short interest or the price in Ambu changes significantly, or do you want to see which specific hedge funds have shorted the stock right now? Good day out there.
- ·3 päivää sittenHard to see the rationale behind the increase Ambu has had the last 6 months. Anyone who can elaborate or are people just buying on a gut feeling?Q4 of the 2024/25 financial year and Q1 and Q2 of 2025/26 were barely as good, so in the spring the market was skeptical towards Ambu. The second half of the recently reported financial statement was better + they are getting some tariff refunds back from the USA, which fall straight into the cash register. They are facing a long series of product launches, and this is presumably interpreted as a catalyst for future growth. Operations yield 16% of revenue and there is no debt, so the market is also starting to sense share buybacks and/or dividends if the extensive product program does not swallow it all. Finally, the entire medtech sector has enjoyed a tailwind since the spring.
- ·3 päivää sittenIs there anyone who can provide a technical analysis of Ambu? Thanks in advance and have a good weekendinput from Investtech: Pt. at resistance/support at 91. Next resistance at 108 in the medium term and 115 in the long term. Buy signal from an inverse-head-and-shoulders pattern upon the breakout up through the resistance at 75.06 kroner. Further rise to 109 kroner or more is signaled. Not from Investtech: Last Friday the price closed for the first time since January above 90 - even above the resistance at 91 - and even at the day's highest price. All in all very positive signals.
- ·3 päivää sittenPrice target raised from 72 to 83 kr. https://www.nordnet.dk/markedet/nyheder/b080350a-c8ad-4425-b021-0171824649e7
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 54 | ||
| 438 | ||
| 338 | ||
| 14 | ||
| 571 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Tuotteita joiden kohde-etuutena tämä arvopaperi
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2027 Q1 - tulosraportti 28.1.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q4 - tulosraportti 5.11. | ||
2026 Q3 - tulosraportti 26.8. | ||
2026 Q2 - tulosraportti 6.5. | ||
2026 Q1 - tulosraportti 4.2. | ||
2025 Q4 - tulosraportti 5.11.2025 |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 359 766 | 359 766 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 359 766 | 359 766 | 0 | 0 |
2026 Q4 - tulosraportti
11 päivää sitten
‧1 t 16 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2027 Q1 - tulosraportti 28.1.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q4 - tulosraportti 5.11. | ||
2026 Q3 - tulosraportti 26.8. | ||
2026 Q2 - tulosraportti 6.5. | ||
2026 Q1 - tulosraportti 4.2. | ||
2025 Q4 - tulosraportti 5.11.2025 |
0,56 DKK/osake
Irtoamispäivä 3.12.
0,45%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·2 t sitten · MuokattuThe buyback supports the share price for a longer time, I think. Probably not something shorters like ... During the program, Ambu will repurchase shares for a total amount of up to DKK 400m from 9 November 2026 until no later than 30 April 2027.
- 3 päivää sittenShort squeeze!?....... asked AI on a Monday morning .... so you can form your own opinion based on your own analysis. I own shares in Ambu: No, Ambu A/S is not in a proper short squeeze right now, but the stock is experiencing upward price pressure and continues to have a noticeable short interest. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) Here is the current status for the Ambu stock at Jyske Bank and the figures from the Danish Financial Supervisory Authority: [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) 1. Short interest is declining, but still noticeable • Current short interest: According to the latest figures from the Danish FSA's list of net short positions, 5.53 % of Ambu's share capital is shorted (as of November 13, 2026). This makes Ambu the fourth most shorted stock in Denmark. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions) • Development in short positions: The share has decreased slightly from around 6.1 % at the end of October 2026 (and a peak of over 7 % earlier in the year). This indicates that some short sellers are already in the process of closing their positions at a controlled pace rather than in panic. [1] (https://www.zirium.dk/analyse/ambu/2026-06-01), [2] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267) 2. Price development shows strong progress – not a panic explosion • Recent price increases: Following the annual report on November 5, 2026 (where the company reported strong growth in Endoscopy Solutions and a share buyback of DKK 400 million), the stock has risen nicely. On Friday, November 13, the stock closed at DKK 91.65 after an increase of 5.04 % on the day and nearly 17 % over the past month. [1] (https://npinvestor.dk/aktier/ambu-a-s/), [2] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12) • Why it is not a short squeeze: A classic short squeeze is characterized by extreme, sudden price increases of 20–50 % or more in a few days driven by forced buybacks. Ambu's rise has been more gradual and supported by concrete financial figures and buyback programs. [1] (https://www.jyskebank.dk/investering/markedet-i-dag/vaerdipapirdetaljer?id=DK0060946788&market=12), [2] (https://npinvestor.dk/aktier/ambu-a-s/) Conclusion Although the increases following the financial report undoubtedly put pressure on the funds that have shorted the stock, the movement looks more like a regular bull run driven by good news combined with the ongoing unwinding of short positions. With over 5.5 % of the shares still shorted, however, there remains a moderate potential for further upward price pressure if the stock continues to rise. [1] (https://www.dfsa.dk/financial-themes/capital-market/company-announcements/aggregated-net-short-positions), [2] (https://npinvestor.dk/aktier/ambu-a-s/), [3] (https://proinvestor.com/nyheder/overblik-disse-selskaber-er-shortet-paa-det-danske-aktiemarked-1793168985267), [4] (https://tradedesk.dk/stock/ambu-b.co) Would you like me to set up a task that notifies you if the short interest or the price in Ambu changes significantly, or do you want to see which specific hedge funds have shorted the stock right now? Good day out there.
- ·3 päivää sittenHard to see the rationale behind the increase Ambu has had the last 6 months. Anyone who can elaborate or are people just buying on a gut feeling?Q4 of the 2024/25 financial year and Q1 and Q2 of 2025/26 were barely as good, so in the spring the market was skeptical towards Ambu. The second half of the recently reported financial statement was better + they are getting some tariff refunds back from the USA, which fall straight into the cash register. They are facing a long series of product launches, and this is presumably interpreted as a catalyst for future growth. Operations yield 16% of revenue and there is no debt, so the market is also starting to sense share buybacks and/or dividends if the extensive product program does not swallow it all. Finally, the entire medtech sector has enjoyed a tailwind since the spring.
- ·3 päivää sittenIs there anyone who can provide a technical analysis of Ambu? Thanks in advance and have a good weekendinput from Investtech: Pt. at resistance/support at 91. Next resistance at 108 in the medium term and 115 in the long term. Buy signal from an inverse-head-and-shoulders pattern upon the breakout up through the resistance at 75.06 kroner. Further rise to 109 kroner or more is signaled. Not from Investtech: Last Friday the price closed for the first time since January above 90 - even above the resistance at 91 - and even at the day's highest price. All in all very positive signals.
- ·3 päivää sittenPrice target raised from 72 to 83 kr. https://www.nordnet.dk/markedet/nyheder/b080350a-c8ad-4425-b021-0171824649e7
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 54 | ||
| 438 | ||
| 338 | ||
| 14 | ||
| 571 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 359 766 | 359 766 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 359 766 | 359 766 | 0 | 0 |









